Pancrelipase: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Pancrelipase (patient information)": Robot: Protecting all pages from category Drug ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
Line 1: Line 1:
{{drug header}}
{{DrugProjectFormSinglePage
|authorTag=


==Why is this medication prescribed==
Pancrelipase is used to improve digestion of foods and prevent frequent, fatty, foul-smelling bowel movements in people who have a condition that affects the pancreas (a gland that produces several substances that the body needs to function normally) such as cystic fibrosis (an inborn disease that causes problems with breathing, digestion, and reproduction), chronic pancreatitis (swelling of the pancreas that does not go away), or a blockage in the passages between the pancreas and the intestine, or who have had surgery to remove all or part of the pancreas or stomach. Pancrelipase is also sometimes used to test how well the pancreas is working. Pancrelipase is in a class of medications called enzymes. Pancrelipase acts in place of the natural substances normally made by the pancreas. It works by breaking down fats, proteins, and starches from food into smaller substances that can be absorbed from the intestine. This allows the body to use these substances for energy and prevents them from being passed as frequent, fatty bowel movements.


==How should this medicine be used==
<!--Overview-->
Pancrelipase comes as a powder, tablet, capsule that contains powder, delayed-release capsule that contains small coated beads, and delayed-release capsule that contains very small coated tablets to take by mouth. It is usually taken with food and plenty of water several times a day, often with every meal or snack. The number of times per day that you take pancrelipase depends on your condition and on how well you respond to treatment. Your doctor will tell you whether you should take pancrelipase before, during, or after meals and snacks. To help you remember to take pancrelipase, take it at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take pancrelipase exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.


You can mix pancrelipase powder or the contents of powder-filled pancrelipase capsules with liquids or soft foods, but be careful not to inhale any of the powder.
|genericName=


If you cannot swallow pancrelipase bead- or tablet-filled capsules whole, you can open the capsules and mix the beads or tablets with a small amount of a soft food such as pudding, applesauce, or gelatin. Certain foods such as dairy products may dissolve the protective coating of the beads or tablets, so ask your doctor before you mix the beads or tablets with any other soft food. Swallow the mixture right after you mix it without chewing or crushing the beads or tablets. After you swallow the mixture, drink a full glass of water or juice right away to wash down the medication.


Swallow pancrelipase powder, tablets, or the contents of opened capsules as soon as you put them in your mouth. Your mouth may become irritated if you suck on the tablets or hold them in your mouth.


Pancrelipase is sold under many brand names, and there are slight differences among the brand name products. Do not switch to a different brand of pancrelipase without talking to your doctor.
|aOrAn=


Your doctor will probably start you on a low dose of medication and gradually increase your dose depending on your response to treatment and the amount of fat in your diet. Be sure to tell your doctor how you are feeling and whether your bowel symptoms improve during your treatment. Do not change the dose of your medication unless your doctor tells you that you should.
a


Pancrelipase may control your symptoms but will not cure your condition. Continue to take pancrelipase even if you feel well. Do not stop taking pancrelipase without talking to your doctor.
|drugClass=


==Other uses for this medicine==
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.


==What special precautions should I follow==
'''Before taking pancrelipase:'''


*tell your doctor and pharmacist if you are allergic to pancrelipase, any other medications, or pork products. If you are taking Ultrase® brand capsules, tell your doctor if you are allergic to simethicone.
|indication=
*tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention iron products. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
*tell your doctor if you have ever had surgery on your intestine and if you have or have ever had any disease of the pancreas that comes and goes, a blockage in your intestine at birth or later in life, short bowel syndrome (intestine shortened by surgery or infection), or inflammatory bowel disease (conditions such as Crohn's disease that cause swelling of the intestine and diarrhea or constipation).
*tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking pancrelipase, call your doctor.


==What special dietary instructions should I follow==
Your doctor or nutritionist will prescribe a diet specific for your nutritional needs. Follow these directions carefully.


Be sure to drink plenty of fluids throughout the day while you are taking this medication, especially if the weather is warm. Talk to your doctor about how much fluid you need to drink.


==What should I do if I forget a dose==
|hasBlackBoxWarning=
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.


==Side effects==
Yes
===Mild side effects===
''Pancrelipase may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:''


*diarrhea
|adverseReactions=
*constipation
*upset stomach
*vomiting
*stomach cramps
*bloating
*gas
*irritation around the anus


===Severe side effects===
''Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:''


*rash or other signs of allergic reaction
*diarrhea that is bloody or does not go away
*black, tarry stools
*stomach pain, cramps, or swelling
*pain or swelling in joints, especially the big toe


Pancrelipase may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
<!--Black Box Warning-->


If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].
|blackBoxWarningTitle=
Title


==What storage conditions are needed for this medicine==
|blackBoxWarningBody=
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not refrigerate this medication. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
<i><span style="color:#FF0000;">ConditionName: </span></i>


==In case of emergency/overdose==
* Content
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.


'''Symptoms of overdose may include:'''
<!--Adult Indications and Dosage-->
*pain or swelling in joints, especially the big toe
*diarrhea


==What other information should I know==
<!--FDA-Labeled Indications and Dosage (Adult)-->
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to pancrelipase.


Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking pancrelipase.
|fdaLIADAdult=


Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
=====Condition1=====


==Brand names==
* Dosing Information
*Creon® 10 Minimicrospheres®
*Creon® 20 Minimicrospheres®
*Creon® 5 Minimicrospheres®
*Ku-Zyme® HP
*Lipram® 4500
*Lipram®-CR10
*Lipram®-CR20
*Lipram®-CR5
*Lipram®-PN10
*Lipram®-PN16
*Lipram®-PN20
*Lipram®-UL12
*Lipram®-UL18
*Lipram®-UL20
*Pancrease®
*Pancrease® MT 10
*Pancrease® MT 16
*Pancrease® MT 20
*Pancrease® MT 4
*Pancrecarb® MS-16
*Pancrecarb® MS-4
*Pancrecarb® MS-8
*Pangestyme®
*Pangestyme® CN 10
*Pangestyme® CN 20
*Pangestyme® MT 16
*Pangestyme® UL 12
*Pangestyme® UL 18
*Pangestyme® UL 20
*Panokase®
*Panokase® 16
*Ultrase®
*Ultrase® MT12
*Ultrase® MT18
*Ultrase® MT20
*Viokase®
*Viokase® 16
*Viokase® 8
==Other names==
*Lipancreatin


[[Category:Gastrointestinal Drugs]]
:* Dosage
{{WikiDoc Help Menu}}
 
{{WikiDoc Sources}}
=====Condition2=====
 
* Dosing Information
 
:* Dosage
 
=====Condition3=====
 
* Dosing Information
 
:* Dosage
 
=====Condition4=====
 
* Dosing Information
 
:* Dosage
 
<!--Off-Label Use and Dosage (Adult)-->
 
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Pediatric Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Off-Label Use and Dosage (Pediatric)-->
 
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Contraindications-->
 
|contraindications=
 
* Condition1
 
<!--Warnings-->
 
|warnings=
 
* Description
 
====Precautions====
 
* Description
 
<!--Adverse Reactions-->
 
<!--Clinical Trials Experience-->
 
|clinicalTrials=
 
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
 
=====Cardiovascular=====
 
 
 
 
=====Digestive=====
 
 
 
 
=====Endocrine=====
 
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
 
=====Metabolic and Nutritional=====
 
 
 
 
=====Musculoskeletal=====
 
 
 
 
=====Neurologic=====
 
 
 
 
=====Respiratory=====
 
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
 
=====Special Senses=====
 
 
 
 
=====Urogenital=====
 
 
 
 
=====Miscellaneous=====
 
 
 
<!--Postmarketing Experience-->
 
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
=====Cardiovascular=====
 
 
 
=====Digestive=====
 
 
 
=====Endocrine=====
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
=====Metabolic and Nutritional=====
 
 
 
=====Musculoskeletal=====
 
 
 
=====Neurologic=====
 
 
 
=====Respiratory=====
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 
 
 
<!--Drug Interactions-->
 
|drugInteractions=
 
* Drug
:* Description
 
<!--Use in Specific Populations-->
 
|useInPregnancyFDA=
* '''Pregnancy Category'''
 
|useInPregnancyAUS=
* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
 
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
 
<!--Administration and Monitoring-->
 
|administration=
 
* Oral
 
* Intravenous
 
|monitoring=
 
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 
* Description
 
<!--IV Compatibility-->
 
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 
<!--Overdosage-->
 
|overdose=
 
===Acute Overdose===
 
====Signs and Symptoms====
 
* Description
 
====Management====
 
* Description
 
===Chronic Overdose===
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacology-->
 
<!--Drug box 2-->
 
|drugBox=
 
 
 
<!--Mechanism of Action-->
 
|mechAction=
 
*
 
<!--Structure-->
 
|structure=
 
*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacokinetics-->
 
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 
<!--Nonclinical Toxicology-->
 
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 
<!--Clinical Studies-->
 
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 
<!--How Supplied-->
 
|howSupplied=
 
*
 
<!--Patient Counseling Information-->
 
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
 
<!--Precautions with Alcohol-->
 
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 
<!--Brand Names-->
 
|brandNames=
 
* ®<ref>{{Cite web | title =  | url =  }}</ref>
 
<!--Look-Alike Drug Names-->
 
|lookAlike=
 
* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
 
|drugShortage=
}}
 
<!--Pill Image-->
 
{{PillImage
|fileName=No image.jpg|This image is provided by the National Library of Medicine.
|drugName=
|NDC=
|drugAuthor=
|ingredients=
|pillImprint=
|dosageValue=
|dosageUnit=
|pillColor=
|pillShape=
|pillSize=
|pillScore=
}}
 
<!--Label Display Image-->
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
<!--Category-->
 
[[Category:Drug]]

Revision as of 13:03, 12 September 2014

Pancrelipase
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content

Overview

Pancrelipase is a that is FDA approved for the {{{indicationType}}} of . There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition1
  • Dosing Information
  • Dosage
Condition2
  • Dosing Information
  • Dosage
Condition3
  • Dosing Information
  • Dosage
Condition4
  • Dosing Information
  • Dosage

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Pancrelipase in adult patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Pancrelipase in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Pancrelipase in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Pancrelipase in pediatric patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Pancrelipase in pediatric patients.

Contraindications

  • Condition1

Warnings

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content
  • Description

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Pancrelipase in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Pancrelipase in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Pancrelipase in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Pancrelipase during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Pancrelipase with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Pancrelipase with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Pancrelipase with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Pancrelipase with respect to specific gender populations.

Race

There is no FDA guidance on the use of Pancrelipase with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Pancrelipase in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Pancrelipase in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Pancrelipase in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Pancrelipase in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Pancrelipase in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Pancrelipase in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Pancrelipase in the drug label.

Pharmacology

There is limited information regarding Pancrelipase Pharmacology in the drug label.

Mechanism of Action

Structure

File:Pancrelipase01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Pancrelipase in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Pancrelipase in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Pancrelipase in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Pancrelipase in the drug label.

How Supplied

Storage

There is limited information regarding Pancrelipase Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Pancrelipase |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Pancrelipase |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Pancrelipase in the drug label.

Precautions with Alcohol

  • Alcohol-Pancrelipase interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)


{{#subobject: 

 |Page Name=Pancrelipase
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage=
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}


{{#subobject: 

 |Label Page=Pancrelipase
 |Label Name=Pancrelipase11.png

}}


{{#subobject: 

 |Label Page=Pancrelipase
 |Label Name=Pancrelipase11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Pancrelipase&oldid=1021172"